White House signs H.R. 7148 into law, tightening rules on PBMs distorting New Jersey drug prices

Donald Trump, the 45th President of the United States, known for his business background and “America First” policy agenda
Donald Trump, the 45th President of the United States, known for his business background and “America First” policy agenda
0Comments

The White House announced that congressional bill H.R. 7148 has been signed into law, which includes reforms targeting pharmacy benefit manager (PBM) practices by shifting compensation away from rebate-linked incentives and expanding transparency requirements, an issue gaining attention in New Jersey. 

According to AJMC, the spending law introduces Medicare Part D PBM reforms designed to reduce incentives tied to higher list prices. The policy “delinks” PBM compensation from rebates and list prices by moving PBMs toward flat administrative fees, a change supporters say can weaken “rebate maximization” and steer plans away from higher-priced drugs that generate bigger rebates.

Under the new provisions described in coverage of the law, PBMs would be required to pass through 100% of rebates, fees, and other remuneration to the payer, with Centers for Medicare & Medicaid Services (CMS) monetary penalties available for noncompliance. The goal, as reported by AJMC, is to ensure rebate dollars do not remain with middlemen and to improve accountability for how savings are handled.

PBMs sit between insurers/payers, drug manufacturers, and pharmacies—negotiating rebates and building formularies and pharmacy networks that shape what patients pay and where they can fill prescriptions. Federal scrutiny has intensified: the FTC’s interim staff report on “prescription drug middlemen” argues PBM concentration and vertical integration can disadvantage patients and independent pharmacies without sufficient transparency.

New Jersey’s Division of Consumer Affairs reported dispensing patterns suggesting the “Big 3” PBMs may steer highly profitable prescriptions to their own affiliated pharmacies. The same analysis estimated PBMs generated about $1.4 billion via spread pricing—billing plan sponsors more than they reimburse pharmacies—an incentive structure that can squeeze independents.

The White House serves as the executive branch office supporting the President and communicates official administration actions through its public “Briefings & Statements” releases. These postings serve as the government’s on-the-record record for presidential actions and policy announcements, archived for public access on WhiteHouse.gov.



Related

Jonathan L. Young, Sr., Commissioner

Camden County issues Code Blue advisory as cold weather approaches

The Camden County Office of Emergency Management has issued a Code Blue Advisory due to dangerously low temperatures forecasted by the National Weather Service.

Reginald Ware, Founder & CEO of BlackDoctor.org

BlackDoctor.org calls for reforms to federal 340B drug pricing program impacting New Jersey

A health and wellness website is calling for increased scrutiny of the 340B Drug Pricing Program, urging patient-centered reforms focused on transparency and accountability.

Louis Cappelli, Jr. Commissioner Director

Camden County launches seasonal pothole repair campaign after harsh winter

As winter ends in Camden County, the Department of Public Works is starting a large-scale effort to repair potholes and address other road concerns across its 1,200 lane miles.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Garden State Times.